Zanamivir for inhal

Ended Awarded

Contract number
0173
Awardee
Awarding agency
Obligated
$76,602

Award facts

Opportunity
Contract value 100% obligated
$76,601.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed price delivery order contract awarded by the Medical Supply Chain component of the Defense agency to Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir. The contract has a ceiling value of $76,601.70 and a completion date of December 6, 2017. It is not designated as a set-aside contract. Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other products to U.S. government agencies, has been awarded this contract to support disease prevention efforts and medication stockpiling initiatives. The company has a range of federal contract vehicles for pharmaceutical goods and services, including a $4.6 million contract with the Defense Logistics Agency Troop Support to provide zanamivir.

Quick answers

Who was awarded contract 0173?

0173 was awarded to Glaxosmithkline, LLC by Medical Supply Chain (Troop Support) on September 7, 2017.

How much is contract 0173 worth?

The government has obligated $76,602 on 0173.

Is contract 0173 an order under another contract?

Yes. 0173 is a delivery order under SPE2DP16D0009, an indefinite delivery contract.

Was contract 0173 competed?

The extent of competition for 0173 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award